Food News and Research

RSS

Summa Health System to implement Agilysys' software solution suite

Agilysys, Inc., a leading provider of innovative information technology and hospitality software solutions, announced today that Summa Health System in Akron, Ohio has implemented a comprehensive suite of software solutions to streamline efficiency and control costs in its food outlets and gift shops.

8 Dec 2009

Veran Medical Technologies' SPiN Drive System receives FDA marketing clearance

Veran Medical Technologies announced today that it received clearance (K091934) from the U.S. Food and Drug Administration (FDA) to market a product for the delivery of instruments through the pulmonary tract. "Veran is excited about this clearance as it allows the company to address a huge unmet clinical need in lung cancer diagnosis and treatment," said Jerome R. Edwards, Veran president and chief executive officer.

8 Dec 2009

FDA probes excessive radiation dose cases

The Associated Press/Wall Street Journal: "Federal health regulators are investigating reports of dangerous radiation levels at two more California hospitals, following earlier unsafe medical scans at a Los Angeles facility. The Food and Drug Administration is probing the use of CT scans at Glendale Adventist Medical Center and Providence St. Joseph Medical Center in Burbank, Calif. The brain scans are used to diagnose strokes.

8 Dec 2009

BHR Pharma files an IND for its BHR-100 intravenous progesterone infusion product

BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.

8 Dec 2009

Eidogen-Sertanty licenses its TIP technology for FDA's National Center for Toxicological Research

Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today they have licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).

8 Dec 2009

A nudge to keep your resolutions on-track

These are all admirable resolutions for the New Year, but studies show that most of them will fall by the wayside. BeMyNudge is a new, breakthrough service that helps keep people on track to achieving their goals.

8 Dec 2009

Arcadia Biosciences' SONOVA 400 receives FDA approval as a dietary supplement ingredient

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the U.S. Food and Drug Administration (FDA) regulatory process for SONOVA™ 400.

8 Dec 2009

Tips for avoiding holiday weight gain

With obesity rates at all time highs, and the season of food, comfort and overindulgence right around the corner, the fear of weight gain is very real for most people. Keep off those pesky holiday pounds by upping fitness this December, and get a jump start on that New Year's resolution with the help of some guidance from Life123.com, a leading source of expert advice.

8 Dec 2009

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

Sickle cell disease, a condition characterized by deformed and dysfunctional red blood cells, is one of the most common genetic blood disorders affecting millions of people around the world, including more than 70,000 Americans (National Heart, Lung, and Blood Institute.

8 Dec 2009

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University of Texas M. D. Anderson Cancer Center reported at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent’s Comprehensive Cancer Center in New York.

8 Dec 2009

Phase III CLL8 trial shows Rituxan plus FC chemotherapy improves patients with CLL

Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.

8 Dec 2009

LCA-GA praises Senators' support in establishing comprehensive program for lung cancer

Today, Lung Cancer Alliance-Georgia (LCA-GA) acknowledged Senators Saxby Chambliss (R-GA) and Johnny Isakson (R-GA) for their leadership and support in establishing the first ever multi-agency, comprehensive program targeted at lung cancer.

8 Dec 2009

Market for personalized medicine in the United States to grow 11 percent annually, shows report

The market for personalized medicine in the United States is already $232 billion, and it is projected to grow 11 percent annually, according to a new report published today by PricewaterhouseCoopers LLP, entitled The Science of Personalized Medicine: Translating the Promise into Practice.

8 Dec 2009

Excess radiation exposure during CT perfusion imaging: FDA issues interim recommendations

As part of an ongoing investigation into cases of excess radiation during CT perfusion imaging of the brain, the U.S. Food and Drug Administration today provided imaging facilities and practitioners with interim recommendations to help prevent additional problems.

8 Dec 2009

NeuroPace's RNS System effective for controlling seizures not treatable by medication in epilepsy patients

NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.

8 Dec 2009

Gentium presents evaluation results of Defibrotide for VOD at the ASH conference

Gentium S.p.A. today announced final clinical trial results from the Company’s Phase II/III Pediatric Prevention trial and Phase III Treatment trial for Defibrotide of Hepatic Veno-Occlusive Disease (VOD), which were presented at the American Society of Hematology Conference (ASH) in New Orleans.

8 Dec 2009

MicroPhage obtains CE mark to market MRSA/MSSA Blood Culture Test in Europe

MicroPhage announced today that it has obtained its CE Mark to market in Europe the first of its instrument-free, rapid tests based on its patented Bacteriophage Amplification technology.

8 Dec 2009

Long-chain omega-3 fatty acids can prevent colorectal cancer

Long-chain omega-3 fatty acids, primarily found in fish and seafood, may have a role in colorectal cancer prevention, according to results presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9, 2009, in Houston.

8 Dec 2009

BD Diagnostics receives FDA clearance on Amplified DNA Assays

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to utilize its BD ProbeTec(TM) Chlamydia trachomatis (CT) Qx and BD ProbeTec(TM) Neisseria gonorrhoeae (GC) Qx Amplified DNA Assays with samples collected during women's routine liquid-based Pap testing for cervical cancer screening.

From BD (Becton, Dickinson and Company) 8 Dec 2009

Food News and Research

Summa Health System to implement Agilysys' software solution suite

Veran Medical Technologies' SPiN Drive System receives FDA marketing clearance

FDA probes excessive radiation dose cases

BHR Pharma files an IND for its BHR-100 intravenous progesterone infusion product

Eidogen-Sertanty licenses its TIP technology for FDA's National Center for Toxicological Research

A nudge to keep your resolutions on-track

Arcadia Biosciences' SONOVA 400 receives FDA approval as a dietary supplement ingredient

Tips for avoiding holiday weight gain

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

CML patients on nilotinib or dasatinib drug achieve better response than imatinib drug

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

Phase III CLL8 trial shows Rituxan plus FC chemotherapy improves patients with CLL

LCA-GA praises Senators' support in establishing comprehensive program for lung cancer

Market for personalized medicine in the United States to grow 11 percent annually, shows report

Excess radiation exposure during CT perfusion imaging: FDA issues interim recommendations

NeuroPace's RNS System effective for controlling seizures not treatable by medication in epilepsy patients

Gentium presents evaluation results of Defibrotide for VOD at the ASH conference

MicroPhage obtains CE mark to market MRSA/MSSA Blood Culture Test in Europe

Long-chain omega-3 fatty acids can prevent colorectal cancer

BD Diagnostics receives FDA clearance on Amplified DNA Assays

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News